MIR logo

MIRION TECHNOLOGIES INC

MIRNYSE
๐Ÿ† #1509 by market capEarnings Oct 26US Equity
$15.28โ–ฒ $0.01 (+0.07%)
Live
1hโ–ผ 0.1%
24hโ–ฒ 0.1%
7dโ–ผ 0.6%
14dโ–ฒ 4.8%
30dโ–ผ 5.7%
1yโ–ผ 31.5%
๐ŸฆMarket Cap
$3.72B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+7.5%
Slowing
๐Ÿ“ŠGross Margin
48.0%
Healthy
๐Ÿ’ตFCF Margin
13.3%
Healthy
โš–๏ธP/S Ratio
3.6x
Fair
Otter Score
40
Weak

Trading Snapshot

Day Range
$15.20 โ€“ $15.56
52-Week Range
$14.11 โ€“ $30.28
Volume
$1.66B
Avg Volume
$1.16B
Shares Outstanding
243.3M
Next Earnings
Sep 7, 2026

Fundamentals Snapshot

Annual Revenue
$925M
Last Q Revenue
$267M
P/E Ratio
154.3
P/S Ratio
3.6x
EPS (TTM)
$0.10
Dividend Yield
0.00%

Why Investors Own MIR

  • โœ“High-growth profile โ€” revenue up -9.8% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 64% gross margin and 19% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$925Mโ–ผ โˆ’10.6% YoY
Gross Margin (TTM)
63.5%โ–ผ โˆ’0.5% YoY
Operating Income (TTM)
$260Mโ–ผ โˆ’10.6% YoY
Free Cash Flow (TTM)
$172Mโ–ผ โˆ’10.6% YoY

About MIRION TECHNOLOGIES INC

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
40/100

Analyst Ratings

โ“˜
Consensus
Buy
15 analysts
Strong Buy3
Buy10
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates